@timlu

Synthetic Biologist | Biotech Entrepreneur | MIT Professor

Joined April 2007
  • Tweets338
  • Following783
  • Followers4.6K
9Media
Dr. Kanya Rajangam, Chief Medical Officer, emphasized that the encouraging SENTI-202 data support advancement into pivotal studies and exploration across additional patient populations, enabled by recent RMAT and Orphan Drug Designations. bit.ly/3XFf7ST $SNTI #ASH2025
1
3
3
1,346
If you missed our CEO, Tim Lu, at the H.C. Wainwright 27th Annual Global Investment Conference, don’t worry — you can watch the full presentation now! 🎥 Replay available here: bit.ly/4mK46dE $SNTI #CellTherapy #AML #CARNK #AcuteMyeloidLeukemia
1
2
5
991
Kanya Rajangam, MD, PhD, President and Chief Medical Officer of $SNTI, shares her excitement for the upcoming data presentation from the SENTI-202 trial at the AACR Annual Meeting being held April 25-30, 2025 bit.ly/3QYtOx5 @AACR
290
559
19
5,501
9,658,010
#MarkYourCalendars: $SNTI leadership will host a conference call and webcast to discuss the new SENTI-202 Phase 1 clinical data being presented at #AACR2025 on Monday, April 28, 2025, at 8:30 AM ET. Access it here: bit.ly/3S668ap #CellTherapy #CARNK #AML @AACR
4
3
4
2,113
Senti Bio to Showcase SENTI-202 Clinical Data and Novel Logic Gated Gene Circuit Mechanism of Action in Oral and Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025 bit.ly/3QYtOx5 $SNTI #CellTherapy #CARNK @AACR #AACR25
295
504
12
4,779
11,428,744
Join us for a live webcast where Senti management and Dr. Stephen Strickland will discuss the positive initial clinical data from the Phase 1 clinical trial of SENTI-202, a Logic-Gated, selective CD33/FLT3-targeting #CARNK #celltherapy. Access here: bit.ly/4eUaKtb $SNTI
1
2
1
12
3,869
We @abscibio are excited to unveil IgDesign™ @NeurIPSConf and present our work at @workshopmlsb @AI4D3 @genbio_workshop! IgDesign is an antibody inverse folding model that we have experimentally validated in our lab. Read the paper here: biorxiv.org/content/10.1101/… #NeurIPS2023
3
35
3
131
21,203
Timothy Lu retweeted
nature
@Nature26 Jul 2023
Nature research paper: Sub-1.4 cm3 capsule for detecting labile inflammatory biomarkers in situ go.nature.com/44YF29F
8
4
45
37,917
Timothy Lu retweeted
SRT@S_R_Thom30 Nov 2022
Replying to @synlogic_tx @Ginkgo
As a parent of a daughter with #HCU #Homocystinuria this is an amazing ray of hope in what the future may hold for her. Very exciting news
1
2
8
Timothy Lu retweeted
WIRED
@WIRED7 Nov 2022
“Similar to how you might program a computer, we can tinker with the DNA of bacteria and have them do things like produce a drug at the right time and the right place, or in this case, break down a toxic metabolite.” wired.trib.al/V6rleLG

This Gulp of Engineered Bacteria Is Meant to Treat Disease

A small study of people with a rare disorder that prevents them from processing protein is an early attempt at creating “living” medicines.

wired.com
1
11
4
38
We're pleased to announce that our CEO and Co-Founder @TimLu will be presenting at the 40th Annual @JPMorgan Healthcare Conference on January 11th at 2PM EST. Learn more here: bit.ly/3t3BrHQ #JPM22
2
1
17
Join our Head of People Dee Olomajeye for a speech and panel Q&A at LEAP HR Life Sciences Digital Event today, on ensuring HR has a people-centered strategic impact across the company and on the business. Register here: bit.ly/3A4Ocm1 #syntheticbiology #genecircuits
1
2
Good morning, Twitter! I recently had the pleasure of joining the BioRad.io podcast to discuss the Synthetic Biology revolution and its applications to developing living medicines. Check it out here! bioradiations.com/bioradio/
3
1
7
Had a lot of fun recording this podcast with @yinhhinh recently. Check out some of the other inspiring stories on here also. Thanks @timlu for making the connection. growthfromfailure.com/podcas…

Growth & Failure

The Growth from Failure podcast, hosted by Yinh Hinh, highlights unique success stories with entrepreneurs, investors, athletes, pioneers of all types - and shares their journey of success WITH their...

growthandfailure.com
3
12
Timothy Lu retweeted
Synlogic@synlogic_tx7 Sep 2021
"Collins is working on synthetic gene circuits and programmable cells ... engineering bacteria to “produce an enzyme ... or a molecule to keep a disease in check.” Work of this kind is being pursued at Collins’ @MIT laboratory, as well as at @synlogic_tx" genengnews.com/topics/genome…

Synthetic Biology Engineers the Next Genomic Revolution

Let information technology boast of killer apps—synthetic biology would rather assemble and program living apps.

genengnews.com
3
3
Join our CSO Gary Lee for a workshop @CAR_TCell Summit 2021 on August 30 on Realizing an “Off-the-Shelf” Future for Cell Therapies. Register here: bit.ly/3zw7kJv #CARTCR #genecircuits #celltherapy #genetherapy #syntheticbiology
1
2
Timothy Lu retweeted
Synlogic@synlogic_tx7 Jun 2021
#Ecoli with an edge – nice piece by @MeganMolteni on some exciting #synbio research and an innovative approach to a new class of medicines. Check out the full article in @statnews: bit.ly/3z104Fu #SynlogicScienceSpotlight @aaas @sxbegle @NewsfromScience
1
3
#News: Excited to share five abstracts were accepted for @ASGCT and @ISCTglobal conferences, highlighting our progress using #genecircuits to engineer #NKcell therapies. Learn more here: bit.ly/3naoc2X #syntheticbiology #NKcells #ASGCT2021 #ISCT2021
2
4
Yesterday we announced positive data from the first part of our phase 1 trial of SYNB8802. We are developing SYNB8802 as a potential treatment for patients who have high oxalate absorption from the GI tract which causes progressive kidney damage. How did we get here? 🧵 1/9
6
18
4
82
Timothy Lu retweeted
Synlogic@synlogic_tx19 Feb 2021
#ICYMI: our @NatureComms article on engineering Synthetic Biotics to treat human diseases. There's increasing appreciation for #synbio and the role microbes play in human #health, addressing specific mechanisms of diseases with high unmet medical need. go.nature.com/3akvwms
3
6
Load more